nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—Hypotensive—Furosemide—dilated cardiomyopathy	0.052	0.0543	CcSEcCtD
Oxymorphone—Lethargy—Spironolactone—dilated cardiomyopathy	0.0258	0.027	CcSEcCtD
Oxymorphone—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.0222	0.0232	CcSEcCtD
Oxymorphone—Drug interaction—Furosemide—dilated cardiomyopathy	0.0205	0.0214	CcSEcCtD
Oxymorphone—Memory impairment—Lisinopril—dilated cardiomyopathy	0.0181	0.0189	CcSEcCtD
Oxymorphone—Mental disability—Furosemide—dilated cardiomyopathy	0.0165	0.0172	CcSEcCtD
Oxymorphone—Oliguria—Lisinopril—dilated cardiomyopathy	0.0154	0.0161	CcSEcCtD
Oxymorphone—Drug interaction—Lisinopril—dilated cardiomyopathy	0.0153	0.016	CcSEcCtD
Oxymorphone—Lethargy—Furosemide—dilated cardiomyopathy	0.0141	0.0147	CcSEcCtD
Oxymorphone—Urinary retention—Furosemide—dilated cardiomyopathy	0.0131	0.0137	CcSEcCtD
Oxymorphone—Dehydration—Furosemide—dilated cardiomyopathy	0.0128	0.0134	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.0126	0.0131	CcSEcCtD
Oxymorphone—Confusional state—Spironolactone—dilated cardiomyopathy	0.0125	0.0131	CcSEcCtD
Oxymorphone—Abdominal distension—Furosemide—dilated cardiomyopathy	0.012	0.0125	CcSEcCtD
Oxymorphone—Somnolence—Spironolactone—dilated cardiomyopathy	0.0111	0.0115	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.0107	0.0112	CcSEcCtD
Oxymorphone—Diplopia—Lisinopril—dilated cardiomyopathy	0.0103	0.0108	CcSEcCtD
Oxymorphone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0103	0.0107	CcSEcCtD
Oxymorphone—Urticaria—Spironolactone—dilated cardiomyopathy	0.00989	0.0103	CcSEcCtD
Oxymorphone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00984	0.0103	CcSEcCtD
Oxymorphone—Dehydration—Lisinopril—dilated cardiomyopathy	0.00961	0.01	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00944	0.00985	CcSEcCtD
Oxymorphone—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00941	0.00982	CcSEcCtD
Oxymorphone—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00934	0.00975	CcSEcCtD
Oxymorphone—Visual impairment—Furosemide—dilated cardiomyopathy	0.00918	0.00959	CcSEcCtD
Oxymorphone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00917	0.00957	CcSEcCtD
Oxymorphone—Eye disorder—Furosemide—dilated cardiomyopathy	0.0089	0.0093	CcSEcCtD
Oxymorphone—Pruritus—Spironolactone—dilated cardiomyopathy	0.0088	0.00919	CcSEcCtD
Oxymorphone—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00879	0.00917	CcSEcCtD
Oxymorphone—Sweating increased—Lisinopril—dilated cardiomyopathy	0.0087	0.00908	CcSEcCtD
Oxymorphone—Angiopathy—Furosemide—dilated cardiomyopathy	0.00865	0.00902	CcSEcCtD
Oxymorphone—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00861	0.00898	CcSEcCtD
Oxymorphone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00851	0.00889	CcSEcCtD
Oxymorphone—Malnutrition—Furosemide—dilated cardiomyopathy	0.00829	0.00866	CcSEcCtD
Oxymorphone—Dizziness—Spironolactone—dilated cardiomyopathy	0.00823	0.00859	CcSEcCtD
Oxymorphone—Flatulence—Furosemide—dilated cardiomyopathy	0.00817	0.00853	CcSEcCtD
Oxymorphone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00808	0.00844	CcSEcCtD
Oxymorphone—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00801	0.00836	CcSEcCtD
Oxymorphone—Vomiting—Spironolactone—dilated cardiomyopathy	0.00791	0.00826	CcSEcCtD
Oxymorphone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00784	0.00818	CcSEcCtD
Oxymorphone—Vision blurred—Furosemide—dilated cardiomyopathy	0.00782	0.00816	CcSEcCtD
Oxymorphone—Headache—Spironolactone—dilated cardiomyopathy	0.0078	0.00814	CcSEcCtD
Oxymorphone—Agitation—Furosemide—dilated cardiomyopathy	0.00762	0.00796	CcSEcCtD
Oxymorphone—Vertigo—Furosemide—dilated cardiomyopathy	0.00745	0.00778	CcSEcCtD
Oxymorphone—Nausea—Spironolactone—dilated cardiomyopathy	0.00739	0.00772	CcSEcCtD
Oxymorphone—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00728	0.0076	CcSEcCtD
Oxymorphone—Hallucination—Lisinopril—dilated cardiomyopathy	0.00711	0.00743	CcSEcCtD
Oxymorphone—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00706	0.00737	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00701	0.00732	CcSEcCtD
Oxymorphone—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00701	0.00732	CcSEcCtD
Oxymorphone—Dry mouth—Furosemide—dilated cardiomyopathy	0.00691	0.00721	CcSEcCtD
Oxymorphone—Confusional state—Furosemide—dilated cardiomyopathy	0.00683	0.00713	CcSEcCtD
Oxymorphone—Shock—Furosemide—dilated cardiomyopathy	0.00666	0.00695	CcSEcCtD
Oxymorphone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00664	0.00693	CcSEcCtD
Oxymorphone—Flushing—Lisinopril—dilated cardiomyopathy	0.00664	0.00693	CcSEcCtD
Oxymorphone—Skin disorder—Furosemide—dilated cardiomyopathy	0.00658	0.00686	CcSEcCtD
Oxymorphone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00654	0.00683	CcSEcCtD
Oxymorphone—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00649	0.00677	CcSEcCtD
Oxymorphone—Anorexia—Furosemide—dilated cardiomyopathy	0.00645	0.00674	CcSEcCtD
Oxymorphone—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00644	0.00673	CcSEcCtD
Oxymorphone—Hypotension—Furosemide—dilated cardiomyopathy	0.00633	0.0066	CcSEcCtD
Oxymorphone—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00626	0.00654	CcSEcCtD
Oxymorphone—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00622	0.0065	CcSEcCtD
Oxymorphone—Flatulence—Lisinopril—dilated cardiomyopathy	0.00613	0.0064	CcSEcCtD
Oxymorphone—Tension—Lisinopril—dilated cardiomyopathy	0.00611	0.00638	CcSEcCtD
Oxymorphone—Nervousness—Lisinopril—dilated cardiomyopathy	0.00604	0.00631	CcSEcCtD
Oxymorphone—Somnolence—Furosemide—dilated cardiomyopathy	0.00602	0.00628	CcSEcCtD
Oxymorphone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00588	0.00614	CcSEcCtD
Oxymorphone—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00587	0.00612	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00584	0.0061	CcSEcCtD
Oxymorphone—Fatigue—Furosemide—dilated cardiomyopathy	0.00584	0.00609	CcSEcCtD
Oxymorphone—Pain—Furosemide—dilated cardiomyopathy	0.00579	0.00604	CcSEcCtD
Oxymorphone—Constipation—Furosemide—dilated cardiomyopathy	0.00579	0.00604	CcSEcCtD
Oxymorphone—Vertigo—Lisinopril—dilated cardiomyopathy	0.00559	0.00584	CcSEcCtD
Oxymorphone—Syncope—Lisinopril—dilated cardiomyopathy	0.00558	0.00583	CcSEcCtD
Oxymorphone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00558	0.00582	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00554	0.00578	CcSEcCtD
Oxymorphone—Palpitations—Lisinopril—dilated cardiomyopathy	0.0055	0.00574	CcSEcCtD
Oxymorphone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00547	0.00571	CcSEcCtD
Oxymorphone—Urticaria—Furosemide—dilated cardiomyopathy	0.00538	0.00561	CcSEcCtD
Oxymorphone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00535	0.00559	CcSEcCtD
Oxymorphone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00535	0.00559	CcSEcCtD
Oxymorphone—Chest pain—Lisinopril—dilated cardiomyopathy	0.0053	0.00553	CcSEcCtD
Oxymorphone—Anxiety—Lisinopril—dilated cardiomyopathy	0.00528	0.00551	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00526	0.00549	CcSEcCtD
Oxymorphone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00518	0.00541	CcSEcCtD
Oxymorphone—Confusional state—Lisinopril—dilated cardiomyopathy	0.00512	0.00535	CcSEcCtD
Oxymorphone—Oedema—Lisinopril—dilated cardiomyopathy	0.00508	0.0053	CcSEcCtD
Oxymorphone—Shock—Lisinopril—dilated cardiomyopathy	0.005	0.00522	CcSEcCtD
Oxymorphone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00499	0.00521	CcSEcCtD
Oxymorphone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00496	0.00518	CcSEcCtD
Oxymorphone—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00493	0.00515	CcSEcCtD
Oxymorphone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00491	0.00513	CcSEcCtD
Oxymorphone—Asthenia—Furosemide—dilated cardiomyopathy	0.00486	0.00507	CcSEcCtD
Oxymorphone—Anorexia—Lisinopril—dilated cardiomyopathy	0.00484	0.00505	CcSEcCtD
Oxymorphone—Pruritus—Furosemide—dilated cardiomyopathy	0.00479	0.005	CcSEcCtD
Oxymorphone—Hypotension—Lisinopril—dilated cardiomyopathy	0.00475	0.00495	CcSEcCtD
Oxymorphone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00463	0.00484	CcSEcCtD
Oxymorphone—Insomnia—Lisinopril—dilated cardiomyopathy	0.00459	0.0048	CcSEcCtD
Oxymorphone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00453	0.00473	CcSEcCtD
Oxymorphone—Somnolence—Lisinopril—dilated cardiomyopathy	0.00452	0.00471	CcSEcCtD
Oxymorphone—Dizziness—Furosemide—dilated cardiomyopathy	0.00448	0.00467	CcSEcCtD
Oxymorphone—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00447	0.00467	CcSEcCtD
Oxymorphone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00442	0.00461	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00439	0.00458	CcSEcCtD
Oxymorphone—Fatigue—Lisinopril—dilated cardiomyopathy	0.00438	0.00457	CcSEcCtD
Oxymorphone—Pain—Lisinopril—dilated cardiomyopathy	0.00434	0.00453	CcSEcCtD
Oxymorphone—Constipation—Lisinopril—dilated cardiomyopathy	0.00434	0.00453	CcSEcCtD
Oxymorphone—Vomiting—Furosemide—dilated cardiomyopathy	0.0043	0.00449	CcSEcCtD
Oxymorphone—Dermatitis—Furosemide—dilated cardiomyopathy	0.00426	0.00445	CcSEcCtD
Oxymorphone—Headache—Furosemide—dilated cardiomyopathy	0.00424	0.00443	CcSEcCtD
Oxymorphone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00419	0.00437	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00415	0.00434	CcSEcCtD
Oxymorphone—Urticaria—Lisinopril—dilated cardiomyopathy	0.00404	0.00421	CcSEcCtD
Oxymorphone—Nausea—Furosemide—dilated cardiomyopathy	0.00402	0.0042	CcSEcCtD
Oxymorphone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00402	0.00419	CcSEcCtD
Oxymorphone—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00402	0.00419	CcSEcCtD
Oxymorphone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00374	0.00391	CcSEcCtD
Oxymorphone—Asthenia—Lisinopril—dilated cardiomyopathy	0.00364	0.0038	CcSEcCtD
Oxymorphone—Pruritus—Lisinopril—dilated cardiomyopathy	0.00359	0.00375	CcSEcCtD
Oxymorphone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00348	0.00363	CcSEcCtD
Oxymorphone—Dizziness—Lisinopril—dilated cardiomyopathy	0.00336	0.00351	CcSEcCtD
Oxymorphone—Vomiting—Lisinopril—dilated cardiomyopathy	0.00323	0.00337	CcSEcCtD
Oxymorphone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0032	0.00334	CcSEcCtD
Oxymorphone—Headache—Lisinopril—dilated cardiomyopathy	0.00318	0.00332	CcSEcCtD
Oxymorphone—Nausea—Lisinopril—dilated cardiomyopathy	0.00302	0.00315	CcSEcCtD
Oxymorphone—OPRD1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00105	0.0251	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00098	0.0233	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000925	0.022	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000925	0.022	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00086	0.0204	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.000811	0.0193	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000811	0.0193	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000781	0.0186	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000726	0.0173	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.000711	0.0169	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000685	0.0163	CbGpPWpGaD
Oxymorphone—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000658	0.0156	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.000601	0.0143	CbGpPWpGaD
Oxymorphone—OPRM1—IL4-mediated signaling events—IL10—dilated cardiomyopathy	0.00058	0.0138	CbGpPWpGaD
Oxymorphone—OPRM1—IL4-mediated signaling events—RPS6KB1—dilated cardiomyopathy	0.000564	0.0134	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000496	0.0118	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000496	0.0118	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000461	0.011	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000435	0.0103	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000435	0.0103	CbGpPWpGaD
Oxymorphone—OPRD1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000418	0.00995	CbGpPWpGaD
Oxymorphone—OPRD1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000418	0.00995	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000404	0.00961	CbGpPWpGaD
Oxymorphone—OPRD1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000389	0.00925	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000388	0.00923	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.000386	0.00918	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000381	0.00907	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000368	0.00874	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000368	0.00874	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000367	0.00872	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000367	0.00872	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000361	0.00858	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00035	0.00831	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000342	0.00812	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000341	0.00811	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00034	0.00809	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000334	0.00795	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000333	0.00791	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000333	0.00791	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000316	0.00752	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00031	0.00737	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00031	0.00737	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000309	0.00735	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000307	0.00729	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000299	0.00712	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000299	0.0071	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000292	0.00693	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000292	0.00693	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000288	0.00685	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000288	0.00684	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000283	0.00673	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000283	0.00672	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000271	0.00645	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000268	0.00638	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000267	0.00636	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000263	0.00624	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000262	0.00622	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000259	0.00616	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000256	0.00608	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000253	0.00602	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000253	0.00602	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000251	0.00597	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000248	0.0059	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000247	0.00586	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000247	0.00586	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000243	0.00577	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000235	0.0056	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000235	0.00559	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000229	0.00545	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000228	0.00542	CbGpPWpGaD
Oxymorphone—OPRD1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000226	0.00538	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000224	0.00533	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000222	0.00528	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000222	0.00528	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000222	0.00528	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000221	0.00526	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000213	0.00506	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00021	0.00499	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000206	0.00491	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0002	0.00475	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000199	0.00473	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000199	0.00472	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000195	0.00463	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00019	0.00451	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000188	0.00446	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000188	0.00446	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000185	0.00439	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00018	0.00428	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00018	0.00428	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000175	0.00415	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000171	0.00406	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000169	0.00402	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000168	0.00399	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000162	0.00385	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000158	0.00375	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000144	0.00343	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000143	0.0034	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000143	0.0034	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000137	0.00326	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000137	0.00326	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000133	0.00317	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000133	0.00316	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00013	0.00309	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00013	0.00309	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000129	0.00306	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000126	0.00298	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000126	0.00298	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000121	0.00287	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00012	0.00286	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000117	0.00278	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000117	0.00277	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000114	0.00271	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000114	0.00271	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000113	0.00269	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00011	0.00262	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000106	0.00252	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000106	0.00252	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000106	0.00252	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000104	0.00248	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000103	0.00244	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000102	0.00242	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.0001	0.00238	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	9.86e-05	0.00234	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.65e-05	0.00229	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.63e-05	0.00229	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.63e-05	0.00229	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.55e-05	0.00227	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.48e-05	0.00225	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.16e-05	0.00218	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	8.96e-05	0.00213	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.77e-05	0.00208	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.67e-05	0.00206	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.65e-05	0.00206	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.32e-05	0.00198	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.16e-05	0.00194	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.11e-05	0.00193	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	8.04e-05	0.00191	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.75e-05	0.00184	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.74e-05	0.00184	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.68e-05	0.00183	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.68e-05	0.00183	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.58e-05	0.0018	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	7.56e-05	0.0018	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.41e-05	0.00176	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.36e-05	0.00175	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.14e-05	0.0017	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.11e-05	0.00169	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	7.03e-05	0.00167	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.03e-05	0.00167	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.91e-05	0.00164	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	6.83e-05	0.00162	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.79e-05	0.00161	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.73e-05	0.0016	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.73e-05	0.0016	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.46e-05	0.00153	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.41e-05	0.00152	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.26e-05	0.00149	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.17e-05	0.00147	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.06e-05	0.00144	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.01e-05	0.00143	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.9e-05	0.0014	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.74e-05	0.00136	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.69e-05	0.00135	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.69e-05	0.00135	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.6e-05	0.00133	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.46e-05	0.0013	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.29e-05	0.00126	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	5.26e-05	0.00125	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	5.21e-05	0.00124	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.18e-05	0.00123	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.12e-05	0.00122	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	4.94e-05	0.00117	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.91e-05	0.00117	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.88e-05	0.00116	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.81e-05	0.00114	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	4.47e-05	0.00106	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.38e-05	0.00104	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.35e-05	0.00103	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.28e-05	0.00102	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.22e-05	0.001	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	4.16e-05	0.000988	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.15e-05	0.000987	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.81e-05	0.000907	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	3.64e-05	0.000866	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.62e-05	0.00086	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.57e-05	0.000848	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.35e-05	0.000796	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.22e-05	0.000766	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	3.08e-05	0.000732	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.94e-05	0.000698	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.88e-05	0.000686	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.53e-05	0.000601	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.48e-05	0.00059	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.14e-05	0.000508	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.98e-05	0.00047	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.86e-05	0.000441	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.81e-05	0.00043	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.73e-05	0.000412	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.63e-05	0.000387	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.47e-05	0.000348	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.21e-05	0.000289	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.18e-05	0.000281	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.06e-05	0.000253	CbGpPWpGaD
